[ARWR] YoY Quarter Result on 30-Jun-2022 [#Q3]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
04-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q3]
Profit Trend
QoQ- -260.44%
YoY- -137.88%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 15,825 32,412 45,891 27,376 42,697 727 -
PBT -173,977 -103,383 -72,046 -29,924 -13,611 20,336 -15,606 49.40%
Tax 0 742 -863 -1,280 0 0 0 -
NP -170,793 -102,946 -71,183 -29,924 -13,611 20,336 -15,606 48.94%
Tax Rate - - - - - 0.00% - -
Total Cost 170,793 118,771 103,595 75,815 40,987 22,361 16,333 47.82%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 -650.53 -219.62 -65.21 -49.72 47.63 -2,145.53 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -1.38 -0.96 -0.67 -0.29 -0.13 0.21 -0.18 40.37%
EPS Diluted -1.38 -0.96 -0.67 -0.29 -0.13 0.21 -0.18 40.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.